Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 1999, p. 2581-2586, Vol. 37, No. 8
Project RETRO-CI, Abidjan, Ivory Coast2;
HIV/AIDS Collaboration, Nonthaburi,
Thailand3; HIV and Retrovirology Branch,
Received 5 February 1999/Returned for modification 7 April
1999/Accepted 26 April 1999
The high degree of genetic diversity within human immunodeficiency
virus type 1 (HIV-1), which includes two major groups, M (major) and O (outlier), and various env subtypes within
group M (subtypes A to J), has made designing assays that will
detect all known HIV-1 strains difficult. We have developed a generic primer set based on the conserved immunodominant region of
transmembrane protein gp41 that can reliably amplify as few as 10 copies/PCR of viral DNA from near-full-length clones representing group
M subtypes A to H (subtypes I and J were not
available). The assay is highly sensitive in detecting plasma viral RNA
from HIV-1 strains of diverse geographic origins representing
different subtypes of HIV-1 group M as well as HIV-1 group O. Of the
253 group M plasma specimens (subtypes A, 68 specimens; B, 71; C, 19;
D, 27; E, 23; F, 33; and G, 12), 250 (98.8%) were amplified by using the gp41 M/O primer set. More importantly, all 32 (100%) group O
plasma samples were also amplified with these primers. In vitro spiking
experiments further revealed that the assay could reliably detect
as few as 25 copies/ml of viral RNA and gave positive signals in
HIV-1-seropositive specimens with plasma copy numbers below the limits of detection by all commercially available viral load assays. In addition, analysis of five seroconversion panels indicated that the assay is highly sensitive for early detection of plasma viremia during the "window period." Thus, the highly sensitive assay will be useful for early detection of HIV-1 in clinical specimens from all known HIV-1 infections, regardless of their genotypes and geographic origins.
0095-1137/99/$04.00+0
Detection of Phylogenetically Diverse Human Immunodeficiency
Virus Type 1 Groups M and O from Plasma by Using Highly Sensitive
and Specific Generic Primers
*
Corresponding author. Mailing address: HIV and
Retrovirology Branch, DASTLR/NCID, Centers for Disease Control and
Prevention, Mail Stop D-12, 1600 Clifton Road, Atlanta, GA 30333. Phone: (404) 639-1036. Fax: (404) 639-2660. E-mail:
rbl3{at}cdc.gov.
Journal of Clinical Microbiology, August 1999, p. 2581-2586, Vol. 37, No. 8
0095-1137/99/$04.00+0
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|